Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2342830C 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
11/20/2008WO2008140863A2 Local field stimulation for cell training of a biological pacemaker
11/20/2008WO2008140064A1 Nutrient composition for prevention and amelioration of lifestyle-related disease
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139941A1 Substituted imidazole compound and use thereof
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008097459A3 Dual-acting antihypertensive agents
11/20/2008WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways
11/20/2008WO2008054825A3 Mixed cell populations for tissue repair and separation technique for cell processing
11/20/2008WO2008033299A3 Use of n-containing spirocompounds for the enhancement of cognitive function
11/20/2008WO2008021439A3 Compositions and methods for treatment of cardiac hypertrophy
11/20/2008WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators
11/20/2008WO2007034445A3 Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287548 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
11/20/2008US20080287544 Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287518 Use of a Benzoyl Derivative of 3-Aminocarbazole For the Treatment of a Disorder Associated With the Production of Prostaglandin E2 (Pge2)
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287503 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287485 Novel indolizine derivatives, method for preparing same, and therapeutic compositions comprising same
11/20/2008US20080287478 Nociceptin Analogues and Uses Thereof
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287429 Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
11/20/2008US20080287412 Therapeutic combination of amlodipine and benazepril/benazeprilat
11/20/2008US20080287411 Optically active dihydropyridine derivative
11/20/2008US20080287407 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
11/20/2008US20080287403 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080287391 Cell Fusion Promoter and Utilization of the Same
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287370 Boronic Acid Salts Useful in Parenteral Formulations
11/20/2008US20080287343 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
11/20/2008US20080286372 Therapeutic compositions for targeted vessel delivery
11/20/2008US20080286354 administering a bile acid e.g ursodiol, ursodiol bicarbonate and ursodiol sulfate, a fibrate e.g. bezafibrate, fenofibrate, gemfibrozil, ciprofibrate and derivatives of 2-phenoxy-2-methylpropanoic acid, and a statin e.g. simvastatin, fluvastatin, pravastatin, atorvastatin to treat chronic hepatitis
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/20/2008US20080286332 Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286285 Methods for Treating Vascular Disease
11/20/2008US20080286282 Novel Use of Sulfonamide Compound in Combination with Angiogenesis Inhibitor
11/20/2008US20080286260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)
11/20/2008US20080286254 Composition comprising licorice polyphenol
11/20/2008US20080286231 Novel inhibitors of glutaminyl cyclase
11/20/2008US20080286203 Inhibitors and Methods of Treatment of Cardiovascular Diseases, and Methods for Identifying Inhibitors
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008CA2683941A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992346A1 Pharmaceutical compositions containing combined platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events
11/19/2008EP1992343A1 Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
11/19/2008EP1991869A2 Methods for the diagnosis of proliferative and/or conformational diseases
11/19/2008EP1991527A2 Polymorphous forms of carvedilol phosphate
11/19/2008EP1991269A1 Compounds and methods for treatment of stroke
11/19/2008EP1991235A1 Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament
11/19/2008EP1991228A1 Treatment of prevention of valvular heart disease with flibanserin
11/19/2008EP1991221A2 Methods for increasing blood flow and/or promoting tissue regeneration
11/19/2008EP1991220A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
11/19/2008EP1991218A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
11/19/2008EP1991217A2 Stearidonic acid for improving cardiovascular health
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1537108B1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1300158B9 Pharmaceutical compositions for angiogenic therapy
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008CN101309915A Compounds and compositions as lxr modulators
11/19/2008CN101309685A Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure
11/19/2008CN101309669A Compositions of lipoxygenase inhibitors
11/19/2008CN101307320A Preparation method and application of recombination human ARC protein with anti - myocardial apoptosis function
11/19/2008CN101307102A Human hypoxia inducible factor-1 alpha recombinant adenovirus carrier and uses thereof
11/19/2008CN101307101A Novel modification-specific signal Conus superfamily toxin and uses thereof
11/19/2008CN101307044A Two crystallographic form of pinocembrin compounds, preparation method and applications for treating diseases
11/19/2008CN101307043A 6,8-dimethylol chrysin and 6,8-dimethylol ether chrysin, method for preparing same and pharmaceutical use
11/19/2008CN101307025A Chuanxiong alcohol carnitine ester compounds
11/19/2008CN101307020A Amlodipine-zinc sulfate salts, preparing process thereof and application thereof
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306202A Ginkgo flavone and lactone -cyclodextrin derivate inclusion complex and preparation method thereof
1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 1595